14-day Premium Trial Subscription Try For FreeTry Free

Explanation to Bollinger's Bands

Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.

Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.

Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation

BandWidth defines the current width of the band.
%b defines the current position within the band.

BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)

Live Samples:

Bollinger Bottleneck Buy Pattern 1
Bollinger Bottleneck Buy Pattern 2
Bollinger Bottleneck Sell Pattern

Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.

Source: http://www.bollingerbands.com

RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of HOTH
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Red day on Monday for Hoth Therapeutics Inc. stock after losing 3.31%
(Updated on May 06, 2024)

Sell candidate since May 03, 2024 Loss -3.31% PDF

The Hoth Therapeutics Inc. stock price fell by -3.31% on the last day (Monday, 6th May 2024) from $1.21 to $1.17. During the last trading day the stock fluctuated 5.13% from a day low at $1.17 to a day high of $1.23. The price has fallen in 5 of the last 10 days but is still up by 1.74% over the past 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -53 thousand shares and in total, 20 thousand shares were bought and sold for approximately $23.82 thousand.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -9.09% during the next 3 months and, with a 90% probability hold a price between $0.97 and $1.43 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

HOTH Signals & Forecast

There are mixed signals in the stock today. The Hoth Therapeutics Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $1.20 and $1.30. A break-up above any of these levels will issue buy signals. Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued. A buy signal was issued from a pivot bottom point on Monday, April 22, 2024, and so far it has risen 1.74%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD).

Buy
Special Signal Notification

Double Bottom Formation

Double Bottom Formation A buy signal from a double bottom formation was found on Monday, April 22, 2024 and based on theory for this formation the price should go up by 19.66% to $1.40 within 24 trading days since signal was issued (Tuesday, May 07, 2024).

Support, Risk & Stop-loss for Hoth Therapeutics Inc. stock

Hoth Therapeutics Inc. finds support from accumulated volume at $1.16 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0.0600 between high and low, or 5.13%. For the last week the stock has had daily average volatility of 5.57%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (HOTH) For The Upcoming Trading Day Of Tuesday 7th

For the upcoming trading day on Tuesday, 7th we expect Hoth Therapeutics Inc. to open at $1.19, and during the day (based on 14 day Average True Range), to move between $1.09 and $1.25, which gives a possible trading interval of +/-$0.0848 (+/-7.25%) up or down from last closing price. If Hoth Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 14.50% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $1.16 (0.85%) than the resistance at $1.35 (15.38%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Hoth Therapeutics Inc. stock A Buy?

Hoth Therapeutics Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -4.197 Sell Candidate Unchanged

Predicted Opening Price for Hoth Therapeutics Inc. of Tuesday, May 7, 2024

Fair opening price May 7, 2024 Current price
$1.19 ( 1.71%) $1.17

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for HOTH

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 1.25 6.84 %
R2 1.23 4.88 %
R1 1.21 3.67 %
Current price: 1.17
Support S1 1.17 -0.250 %
S2 1.15 -1.46 %
S3 1.13 -3.42 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 1.46 24.79 %
R2 1.38 17.95 %
R1 1.35 15.38 %
Current price 1.17
Support S1 1.16 -0.85%
S2 1.15 -1.71%
S3 0 .

FAQ

What is the symbol for Hoth Therapeutics Inc. Stock and on which exchange is it traded?
The symbol for Hoth Therapeutics Inc. is HOTH and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Hoth Therapeutics Inc. Stock?
Hoth Therapeutics Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

How to buy Hoth Therapeutics Inc. Stock?
Hoth Therapeutics Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Hoth Therapeutics Inc. Stock.

What's the current price of Hoth Therapeutics Inc. Stock?
As of the end of day on the May 06, 2024, the price of an Hoth Therapeutics Inc. (HOTH) share was $1.17.

What is the 52-week high and low for Hoth Therapeutics Inc. Stock?
The 52-week high for Hoth Therapeutics Inc. Stock is $95.57 and the 52-week low is $69.42.

What is the market capitalization of Hoth Therapeutics Inc. Stock?
As of the May 06, 2024, the market capitalization of Hoth Therapeutics Inc. is 5.72M.

When is the next earnings date for Hoth Therapeutics Inc.?
The upcoming earnings date for Hoth Therapeutics Inc. is May 20, 2024.
Click to get the best stock tips daily for free!

About Hoth Therapeutics Inc.

Hoth Therapeutics. Hoth Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for unmet medical needs. It is involved in the development of HT-001, a topical formulation for the treatment of patients with rash and skin disorders associated with initial and repeat courses of tyrosine kinase epidermal growth factor receptor inhibitor therapy; HT-KIT to treat mast-cell derived cancers and anaphylaxis; HT-ALZ for the treatment ... HOTH Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT